COMMUNIQUÉS West-GlobeNewswire
-
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
11/06/2026 -
Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
11/06/2026 -
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11/06/2026 -
FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer
11/06/2026 -
Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
11/06/2026 -
Glass House Brands Announces the Filing of Shelf Prospectus and At-The-Market Distribution Program
11/06/2026 -
CARPL.ai Partners with Enlitic to Accelerate AI Validation for Imaging Customers
11/06/2026 -
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
11/06/2026 -
Tilray Medical Allemagne lance ARX™, une nouvelle marque de cannabis médicinal haut de gamme cultivé en Allemagne
11/06/2026 -
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
11/06/2026 -
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/06/2026 -
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
10/06/2026 -
Fennec Announces Results of Annual Meeting
10/06/2026 -
Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/06/2026 -
110 Millions de Dollars de Financements Cumulés pour Accélérer le Lancement Commercial de Genio aux États-Unis
10/06/2026 -
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
10/06/2026 -
Information on the total number of voting rights and shares
10/06/2026 -
Nyxoah Announces Closing of Underwritten Public Offering
10/06/2026 -
SafeSpace Global Announces Launch of New Addiction Treatment Vertical, Supported by Signed Master Services Agreement and Conditional $2 Million Funding Commitment
10/06/2026
Pages